Cynata Therapeutics Limited’s (CYP) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Cynata Therapeutics Limited is a Sell.
Cynata Therapeutics Limited’s (CYP) 20-Day exponential moving average is 0.01, while Cynata Therapeutics Limited’s (CYP) share price is AU$0.01, making it a Buy.
Cynata Therapeutics Limited’s (CYP) 50-Day exponential moving average is 0.02, while Cynata Therapeutics Limited’s (CYP) share price is AU$0.01, making it a Sell.
Cynata Therapeutics Limited’s (CYP) 10-Day exponential moving average is 0.01, while Cynata Therapeutics Limited’s (CYP) share price is AU$0.01, making it a Sell.
Cynata Therapeutics Limited’s (CYP) 100-Day exponential moving average is 0.04, while Cynata Therapeutics Limited’s (CYP) share price is AU$0.01, making it a Sell.
Cynata Therapeutics Limited’s (CYP) stock price is AU$0.01 and Cynata Therapeutics Limited’s (CYP) 50-day simple moving average is 0.01, creating a Buy signal.
Cynata Therapeutics Limited’s (CYP) stock price is AU$0.01 and Cynata Therapeutics Limited’s (CYP) 100-day simple moving average is 0.01, creating a Buy signal.
Cynata Therapeutics Limited’s (CYP) stock price is AU$0.01 and Cynata Therapeutics Limited’s (CYP) 200-day simple moving average is 0.15, creating a Sell signal.